Syntheses and adrenergic agonist properties of ring-fluorinated isoproterenols

Journal of Medicinal Chemistry
1982.0

Abstract

2-Fluoro-, 5-fluoro-, and 6-fluoroisoproterenol were synthesized by reduction of the Schiff base formed between the corresponding ring-fluorinated 3,4-bis(benzyloxy)phenethanolamine and acetone, followed by reductive debenzylation in the presence of oxalic acid to yield crystalline neutral oxalates. The apparent beta-adrenergic potencies were determined in the isolated guinea pig atria. 2-Fluoro- and 5-fluoroisoproterenol were equipotent with (+/-)-isoproterenol, while 6-fluoroisoprotenol was virtually inactive. No alpha-adrenergic agonist activity (guinea pig aorta) was shown by any of the fluoroisoproterenols. Displacement of alpha- and beta-specific radioligands from isolated membrane preparations from rat brain by the fluoroisoproterenols were in agreement with the responses of the organ preparations. Thus, the apparent fluorine-induced specificity is due to specificity at the receptor binding site. The effects of fluorine substitution are discussed with regard to the apparent negative influence of the 6-fluoro substituent on the beta-agonist properties of isoproterenol, the lack of any increase in potency due to the 2-fluoro substituent, and the possibility of fluorine-induced changes in the electron density of the aromatic ring as a possible rational for the fluorine-induced specificity of both the fluoroisoproterenols and the fluoronoirepinephrines.

Knowledge Graph

Similar Paper

Syntheses and adrenergic agonist properties of ring-fluorinated isoproterenols
Journal of Medicinal Chemistry 1982.0
Effect of fluorine substitution on the adrenergic properties of 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol
Journal of Medicinal Chemistry 1991.0
Synthesis and adrenergic activity of ring-fluorinated phenylephrines
Journal of Medicinal Chemistry 1986.0
Synthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrines
Journal of Medicinal Chemistry 1979.0
Syntheses and adrenergic activities of ring-fluorinated epinephrines
Journal of Medicinal Chemistry 1988.0
Syntheses of (R)- and (S)-2- and 6-Fluoronorepinephrine and (R)- and (S)-2- and 6-Fluoroepinephrine:  Effect of Stereochemistry on Fluorine-Induced Adrenergic Selectivities
Journal of Medicinal Chemistry 2000.0
Syntheses of 2,5- and 2,6-difluoronorepinephrine, 2,5-difluoroepinephrine, and 2,6-difluorophenylephrine: effect of disubstitution with fluorine on adrenergic activity
Journal of Medicinal Chemistry 1993.0
Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities
European Journal of Medicinal Chemistry 2014.0
Conformationally defined adrenergic agents. 1. Design and synthesis of novel .alpha.2-selective adrenergic agents: electrostatic repulsion based conformational prototypes
Journal of Medicinal Chemistry 1985.0
Synthesis and structure-activity relationships among .alpha.-adrenergic receptor agonists of the phenylethanolamine type
Journal of Medicinal Chemistry 1980.0